Articles Posted in Mass Torts

In this post, we will provide a status update on what’s happening in the Atrium C-Qur hernia mesh litigation.

The Atrium hernia mesh MDL (Atrium Medical Corp. C-Qur Mesh Products Liability Litigation 16-md-2753) has over 2,500 cases consolidated in the U.S. District Court for New Hampshire. This is the smallest of the three hernia mesh MDLs that are currently pending around the country.

As of September 2022, the number lawsuits pending in the Atrium hernia mesh class action(the smallest of the big 3 hernia mesh MDLs) increased by 17 over the last monthly period (August 15 to September 15). This brings the total number of pending cases up to 3,308.

Over 60,000 women in the U.S. get diagnosed with uterine cancer every year, making cancer of the uterus the 2nd most common female cancer. Recently, uterine cancer has been linked to exposure to certain chemicals, putting this disease at the center of several mass torts, including hair relaxer lawsuits and Camp Lejeune toxic water lawsuits. On this page we provide a simple overview of uterine cancer from a medical standpoint and look at how it has become involved in litigation.

The Uterus

The uterus is the largest female reproductive organ. This pear-shaped organ is often called the “womb” and is where human life begins in the form of fetal development during pregnancy. The uterus is comprised of 3 separate parts: (1) fundus, (2) isthmus, and (3) cervix.

Surgimesh is a new type of hernia mesh implant made from non-woven polypropylene microfibers. The use of individual fibers of polypropylene was intended to make the Surgimesh smaller than other hernia mesh products and less prone to biocompatibility problems and other post-surgery complications. The design of the Surgimesh is therefore distinct from the design of many other hernia mesh devices that have generated thousands of product liability lawsuits in recent years (e.g., Ethicon Physiomesh, Atrium C-Qur, etc.).

A recently filed product liability lawsuit in New Mexico alleges that the Surgimesh has the same dangerous design flaws as the other polypropylene hernia mesh implants. This new Surgimesh lawsuit could potentially be the first of many and open a new front in the hernia mesh mass tort ligation.

About Surgimesh

New research has revealed that cow-milk infant formulas can increase the risk of a deadly neonatal condition called necrotizing enterocolitis (NEC) in premature infants.

This has prompted a growing number of lawsuits against the manufacturers of infant formulas Similac (Abbott Laboratories) and Enfamil (Mead Johnson) by parents of premature infants who were fed with formula and developed NEC. The lawsuits allege that Abbott and Mead negligently failed to warn parents and doctors about the NEC risk their products posed for preemies.

There are currently around 60 NEC infant formula lawsuits pending in both state and federal courts around the country, but hundreds and possibly thousands more are expected to be filed in the near future. This has prompted both Abbott and Mead to request that all NEC lawsuits in federal courts be consolidated into a new MDL. In this post, we will look at the MDL requests and speculate on the most likely venue and what it might mean for the NEC litigation moving forward.

Procter & Gamble issued a recall of 30 dry conditioners and shampoos because these products may contain benzene, a cancer-causing chemical P&G recalled aerosol spray products will familiar names such as Aussie, Pantene, Herbal Essence, and Waterless. dry shampoo products from Old Spice and Hair Food.

The products were made by Proctor & Gamble and distributed nationwide through online sales like Amazon and through traditional retailers.

Is this a big deal or a little deal?  Is the Benzene risk real?  This post talks about the recall and what it means.

Risperdal lawsuits have have mostly been resolved as of 2024 after a global settlement was reached.  We have updated this post in 2024 to talk about the Risperdal settlements and are leaving the rest of this post up for informational purposes.  Our lawyers are no longer seeking new claims.

2024 Risperdal Litigation Update

The lawsuits were primarily based on allegations that Risperdal, an antipsychotic medication, led to the development of gynecomastia in boys and young men, a condition characterized by the growth of breast tissue.

The vaginal mesh cases are heating up everywhere as plaintiffs’ lawyers, who frankly smell blood, are pushing with greater vigor to get and hold trial dates.  Multi-million dollar verdicts will do that.

In the Boston Scientific transvaginal mesh cases, lawyers are pushing fast to get a trial date and are expected to get one soon.  How do you define “soon” in tort law?  Early next year.

All these federal cases have been consolidated in an MDL under a good judge in West Virginia.   The class action lawsuit against Boston Scientific contents the mesh that was supposed to protect them from pelvic organ prolapse or stress urinary incontinence has done nothing but make their health problems far worse.

Contact Information